Team finds breast cancer gene linked to disease spread

January 06, 2009

A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death.

The gene, called "Metadherin" or MTDH, is located in a small region of human chromosome 8 and appears to be crucial to cancer's spread or metastasis because it helps tumor cells stick tightly to blood vessels in distant organs. The gene also makes tumors more resistant to the powerful chemotherapeutic agents normally used to wipe out the deadly cells.

In identifying the genetic mechanism at play in the metastasis of breast cancer, the scientists may have answered one of the biggest mysteries in cancer research and paved the way for new drugs that could thwart the gene's diabolical actions.

"Inhibiting this gene in breast cancer patients will simultaneously achieve two important goals -- reduce the chance of recurrence and, at the same time, decrease the risk of metastatic dissemination," said Yibin Kang, an assistant professor of molecular biology at Princeton, who led the research. "Clinically, these are the two major reasons why breast cancer patients die from the disease."

The work is described in the Jan. 6 edition of Cancer Cell.

The discovery is important for several other reasons, according to Michael Reiss, another author of the paper and director of the Breast Cancer Research Program at The Cancer Institute of New Jersey, a part of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.

"Not only has a new metastasis gene been identified, but this also is one of a few such genes for which the exact mode of action has been elucidated," said Reiss, also a professor of medicine, molecular genetics and microbiology at UMDNJ-Robert Wood Johnson Medical School. "That gives us a real shot at developing a drug that will inhibit metastasis."

The multidisciplinary research strategy used by the team to pinpoint the gene in breast cancer patients also could be used to find other genes involved in the spread of other cancers, scientists said.

"The potential health implications of this study are significant," Kang said.

The discovery is based on three years of work, using an approach that combines the emerging science of integrative genomics with the classical methods of clinical research and laboratory experiments.

"This paper is a great illustration of the way in which bioinformatics can be synergistically combined with experimental work to produce important results," said David Botstein, director of Princeton's Lewis-Sigler Institute for Integrative Genomics.

From the beginning, the scientists were looking for a way to understand the dreaded process of metastasis, the term describing what happens when cancer spreads to distant vital organs, such as the lungs, liver, brain and even the bones.

As the scientists well understood, patients whose breast cancer can be confined to the breast have the best chances at survival. The five-year survival rates, as compiled by the National Cancer Institute, illustrate the difference between localized and metastatic cancer: 98.1 percent of patients with localized breast cancer survive five years after diagnosis, as opposed to 27.1 percent for patients with cancer that has traveled beyond the lymph nodes to bodily organs, according to the federal agency's statistics.

In recent years, researchers have used advanced techniques such as DNA microarray technology to try and identify genetic profiles of the so called "poor prognosis" tumors -- those that are likely to come back after the initial treatment and are most likely to spread beyond the breast. Such studies, though useful in predicting outcomes, have perplexingly offered up differing gene "signatures," making it difficult to identify overlapping, functionally relevant genes that might be important targets for therapeutic intervention.

The scientists in this study addressed this problem by using an innovative computational biology approach. They re-analyzed massive clinical breast cancer databases and found that study after study showed one area in common -- a very small region in human chromosome 8 called 8q22. They found that this area of the chromosome is repeated many times in the genomes of poor-prognosis breast tumors. Some chromosomes contained as many as eight copies or "repeats" of the genetic segment. Most normal DNA sequences contain only two copies of a given gene, conveyed from the genomes of the male and female parents.

Next, the team studied breast tumor samples collected from patients at The Cancer Institute of New Jersey. In doing so, the researchers were able to validate the computational prediction, confirming that the genetic sequence identified in the database was overproduced in the DNA of the poor-prognosis tumor samples.

The researchers went on to discover that among a handful of genes in the 8q22 region, MTDH is responsible for the aggressive behavior of poor-prognosis tumors. They used recombinant DNA technology to enhance the expression of individual genes in the region, one by one, in breast tumor cells and tested their metastatic behavior in laboratory mice.

The scientists found that MTDH-overexpressing tumors are more likely to metastasize to the lungs, other vital organs and bones. Importantly, these tumors were also found to be more resistant to a wide range of chemotherapeutic agents, including paclitaxel, cisplatin and adriamycin. When researchers genetically altered the cancer cells to reduce the expression of MTDH, these tumor cells become less able to metastasize and more likely to be eliminated by chemotherapy agents.

"This is probably one of the first examples of a novel class of dual functional breast cancer genes that cause both metastasis and chemoresistance," Kang said.

Once the team had identified the specific gene, its scientists were able to re-examine the tumor samples. "By analyzing 250 breast tumor samples from patients, we found that this gene is amplified and overexpressed in over 30 to 40 percent of breast cancer cases," Kang said. "This indicates that new drugs against Metadherin may potentially benefit a large population of breast cancer patients."

Gene expression is the translation of information encoded in a gene into proteins that determine an organism's characteristics. Since only a fraction of genes in a genome are expressed in a given cell, genes that are turned "on" are viewed by scientists as a major signal that controls the biology of both normal and malignant cells.

Breast cancer is caused by a malignant tumor that develops from cells in the breast. The most common sign of breast cancer is a new lump or mass in the breast. Scientists once thought that breast cancer spreads first to nearby tissue and underarm lymph nodes before spreading to other parts of the body. They now believe cancer cells may break away from the primary tumor in the breast and begin to metastasize even when the disease is in an early stage.

The team also found that the double menaces of MTDH may be involved in the progression of other types of cancers, including prostate cancer.

The work was funded by a Department of Defense Era of Hope Scholar Award and grants from the National Institutes of Health, the American Cancer Society, the Susan G. Komen Foundation and the New Jersey Commission on Cancer Research.

The Department of Defense awards, created in 2004, were designed to provide substantial funds and support for exceptionally talented, emerging breast cancer researchers -- individuals who had demonstrated extraordinary creativity, vision and productivity, according to Capt. E. Melissa Kaime, a physician who is director of the U.S. Army Congressionally Directed Medical Research Programs.

"This award mechanism seeks the 'best and the brightest' early-career researchers who will challenge current dogma and convention and who are the future innovators of breast cancer research," Kaime said. "Era of Hope Scholar Dr. Kang has already made exciting research achievements, including his latest manuscript in Cancer Cell, and he is only halfway into his five-year, $3.8 million award. The Breast Cancer Research Program sees a promising and hopeful future with Era of Hope Scholars like Dr. Kang dedicated to ending this disease."

Guohong Hu, a postdoctoral research associate in Princeton's Department of Molecular Biology, is the first author on the paper. In addition to Kang and Reiss, other authors include: Robert Chong, a 2007 Princeton graduate who is now a research assistant in Princeton's Department of Molecular Biology; Qifeng Yang, who was at UMDNJ-Robert Wood Johnson Medical School and is now in the Department of Breast Surgery at Qilu Hospital of Shandong University in China; Yong Wei, a postdoctoral research associate in Princeton's Department of Molecular Biology; Andres Blanco, a graduate student in Princeton's Department of Molecular Biology; Feng Li, an associate research scholar in Princeton's Department of Molecular Biology; Jessie Au, Distinguished University Professor in the College of Pharmacy at Ohio State University; and Bruce Haffty, professor and chair of the Department of Radiation Oncology at UMDNJ-Robert Wood Johnson Medical School and chief of radiation oncology at The Cancer Institute of New Jersey.

Princeton University

---

---

	Fight Now: Eat & Live Proactively Against Breast Cancer by Aaron Tabor, MD Dr. Tabor’s FIGHT NOW book provides information on lifestyle choices that might improve breast health and overall health. The purpose of Dr. Tabor’s medical research is to empower you to become proactive against breast cancer now with specific food and lifestyle choices. We can make specific food and lifestyle choices to lower the risk of getting breast cancer, risk of recurrence, and risk of dying from breast cancer. The only alternative is to be reactive after you get breast cancer or have a recurrence of breast cancer. The choice is clear Whether you are currently fighting breast cancer; are a survivor; or, simply trying to lower your risk, Dr. Tabor’s FIGHT NOW book will give you concise, critical information that you can start using today. You don’t have to read...
	Just Get Me Through This!: A Practical Guide to Coping with Breast Cancer by Deborah A. Cohen (Author), Robert M. Gelfand (Author)
	The Breast Cancer Companion: A Guide for the Newly Diagnosed by Nancy Sokolowski (Author), Valerie Rossi (Author), Richard Zelkowitz (Foreword) Named a 2010 Best Consumer Health by the American Journal of Nursing The Breast Cancer Companion is a step-by-step guide through treatment for the 2 million women living with breast cancer in the United States. It provides ample space and encouragement to record questions, thoughts and feelings, doctor's appointments, medications, and contact information for the oncology team and others. The book also covers myriad other details that are often lost in the trauma and emotion of diagnosis and illness. The book helps women to be well-organized, well-informed, and have peace of mind so that, even in the midst of their breast cancer treatment they remain focused on what matters most: becoming well and achieving a healthy outcome. Special features include a calendar to help with...
	Chicken Soup for the Breast Cancer Survivor's Soul: Stories to Inspire, Support and Heal (Chicken Soup for the Soul) by Jack Canfield (Author), Mark Victor Hansen (Author), Mary Olsen Kelly (Author) Your support group in a book, filled with boundless strength and profound hope - until the fight is won. Along with the shock, fear and loss many women face upon a breast cancer diagnosis comes unexpected strength, wisdom, and strong networks of sharing, support and healing. In Chicken Soup for the Breast Cancer Survivor's Soul, survivors and their family members talk openly about how difficult their fight with breast cancer has been and how they made it through the dark times with a belief in a higher power and the support of those closest to them. Find strength in the encouraging stories of how family members confront their fears and show genuine affection for one another through gestures such as a granddaughter cutting the hair off of all her dolls so that they will look more like...
	Breast Cancer: 50 Essential Things to Do by Greg Anderson (Author), Erica A. Harvey (Introduction), Christine Northrup MD (Introduction) 2.5 million women in the U.S. have had a breast cancer diagnosis; more than 200,000 women are diagnosed each year. While recovery and survival rates have improved, selecting a treatment plan can be confusing and overwhelming.Breast Cancer: 50 Essential Things You Can Do offers a roadmap for women facing breast cancer. Cancer-survivor Greg Anderson, a recognized pioneer in the field of integrated cancer care, has guided tens-of-thousands of cancer patients to health and healing over the past 25 years, through his books and his Cancer Recovery Foundation. In this new book he offers critical information about the major issues patients face following a breast cancer diagnosis, and shows how to implement a comprehensive recovery plan that maximizes opportunity for healing and recovery.This is...
	Uplift: Secrets from the Sisterhood of Breast Cancer Survivors by Barbara Delinsky (Author) Barbara Delinsky's 1998 bestseller, COAST ROAD, featured a heroine who was a breast cancer survivor. To this day, it is the book that generates more mail than any of her others. That fact, combined with Barbara's ongoing commitment to breast cancer research, led her to her first book of nonfiction. Not a medical book -- there is no discussion of the pros and cons of a particular treatment or hospital or doctor -- UPLIFT is rather a collection of hundreds of pieces of practical and inspiring tidbits collected from survivors and their on everything from what kind of deodorant to use during radiation treatment to the best kinds of exercise aftloved ones. Think of it as "The Girlfriends' Guide" to breast cancer, with hints on everything from what kind of deodorant to use during radiation...
	Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer by John Link (Author) A completely updated edition of the definitive guide for patients with breast cancer The new fourth edition of The Breast Cancer Survival Manual provides essential updates on treatment and care, enhancing the basic information that has made this the most trusted guide for women diagnosed with breast cancer for the past decade. This edition includes the most current advice on • getting a second opinion: why it's important, what questions    to ask, and how to decide which team of doctors is best for you • updates on genetic testing and how doctors are using    the results to tailor care for each patient • navigating new types of radiation, the herceptin    breakthrough, and improved reconstruction surgeries Conscious of the rapidly evolving spectrum of...
	Dr. Susan Love's Breast Book, 5th Edition (A Merloyd Lawrence Book) by Susan M. Love MD (Author), Karen Lindsey (Contributor) Dr. Susan Love’s Breast Book has long been the bible for the newly diagnosed. In this completely revised fifth edition, it also becomes a guide for those at risk of getting breast cancer, survivors interested in the consequences of their treatment, and anyone who wants to understand the new research about how the local environment influences the manifestations and treatments of many different kinds of breast cancer. Major advances being made in genetic research today mean that prevention and treatment can work not only to get rid of mutated cells (through chemo or surgery), but also to change the environment around the cells (through hormone therapy, exercise, and stress reduction). Among other promising developments discussed are advances in imaging, recognition of breast density as a...
	Dancing With Fear: Tips and Wisdom from Breast Cancer Survivors by Leila Peltosaari (Author) Tips and wisdom from breast cancer survivors. 125 women share their real-life experience through treatments, recovery, aftermath, and reclaiming life after breast cancer. Sections include: > Finding the tumor > Dealing with doctors and surgeries > Lymphedema > Chemotherapy and radiation > Tamoxifen and aromatase inhibitors > Fear of recurrence > Complementary and alternative treatments > Optimism and pessimism > Support and humor > Spirituality and facing death
	The Breast Cancer Caregiver's Survival Guide: Practical Tips for Supporting Your Wife through Breast Cancer by Rick and Becky Kraemer One of the worst possible things has happened to you. You’ve gotten the bad news from your wife’s doctor, and the two of you are either facing breast cancer treatments, or are in the middle of them now. We’re here to help. In 2000, Becky was diagnosed with breast cancer, and completed extensive treatments (surgery, chemotherapy, radiation, hormone therapy). She is currently in remission and leading a normal, healthy, and athletic lifestyle. This booklet is in response to the questions we’ve received from men looking for practical advice on supporting their wives through this difficult time.